NovaBay Pharmaceuticals, Inc. (NBY) stock has fallen -37.39% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NBY stock a score of 4 out of a possible 100. That rank is influenced by a fundamental score of 0. NBY stock has a mean target price of $1.90. This means analysts expect the stock to gain 163.89% over the next 12 months. NBY's rank also includes a short-term technical score of 2. The long-term technical score for NBY is 11.
NovaBay Pharmaceuticals, Inc. (NBY) Stock Gains 24.14% This Week: Is It a Good Pick?
NBY has an Overall Score of 4. Find out what this means to you and get the rest of the rankings on NBY!